Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Bou-Jaoudeh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|April 21, 2025
Advancing Potency Assay Development for Advanced Therapy Medicinal Products: A Comprehensive Approach and Regulatory InsightsAlaa Abdellatif, Melissa Bou Jaoudeh, Alex Zwiers, et al.
European Journal of Immunology|December 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion TechnologyVictoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, et al.
Communications Biology|March 6, 2020
Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cellsAnupama Karnam, Naresh Rambabu, Mrinmoy Das, et al.
Haematologica|January 19, 2023
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A miceMelissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2024
High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitroRohini Sekar, Angelina Mimoun, Melissa Bou-Jaoudeh, et al.
Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|April 21, 2025
Advancing Potency Assay Development for Advanced Therapy Medicinal Products: A Comprehensive Approach and Regulatory InsightsAlaa Abdellatif, Melissa Bou Jaoudeh, Alex Zwiers, et al.
European Journal of Immunology|December 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion TechnologyVictoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi, et al.
Communications Biology|March 6, 2020
Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cellsAnupama Karnam, Naresh Rambabu, Mrinmoy Das, et al.
Haematologica|January 19, 2023
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A miceMelissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2024
High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitroRohini Sekar, Angelina Mimoun, Melissa Bou-Jaoudeh, et al.
Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.
Pageof 1